title: [Progress in the elimination of measles and rubella in the WHO European Region].
abstract: Substantial progress has been made in the World Health Organization (WHO) European Region toward reaching the goal of measles and rubella elimination. We analyzed the surveillance data of 2012 on measles and rubella for age-group, diagnosis confirmation status (clinical, laboratory-confirmed and epidemiologically linked), vaccination status, and measles-related deaths. For 2012, there were 23,871 measles cases and 29,361 rubella cases reported in the region, mostly among unvaccinated persons. Almost one in three patients with measles and one in five patients with rubella were aged 20 years and older. In a few countries, widespread outbreaks or indigenous transmission of measles persisted in 2012. While most countries in the region have controlled rubella, a small number still reported a high incidence and several outbreaks. Therefore, more efforts are required to achieve the goal of eliminating measles and rubella in the WHO European Region by 2015, particularly in high-incidence countries. The WHO measles and rubella elimination plan stipulates that all countries should achieve and maintain the required high vaccination coverage while conducting high-quality surveillance.
authors.affiliation: WHO Regional Office for Europe, UN City, Marmorvej 51, 2100, Copenhagen Ø, Dänemark. mms@euro.who.int
authors.forename: M
authors.initials: M
authors.lastname: Muscat
authors.forename: D
authors.initials: D
authors.lastname: Jankovic
authors.forename: A
authors.initials: A
authors.lastname: Goel
authors.forename: R
authors.initials: R
authors.lastname: Butler
authors.forename: D
authors.initials: D
authors.lastname: Pfeifer
mesh_terms: D017677:Age Distribution; D004196:Disease Outbreaks / Q000517:prevention & control* / Q000706:statistics & numerical data*; D005060:Europe / Q000453:epidemiology; D005858:Germany / Q000453:epidemiology; D006801:Humans; D015994:Incidence; D008457:Measles / Q000453:epidemiology* / Q000517:prevention & control*; D008458:Measles Vaccine / Q000627:therapeutic use; D018570:Risk Assessment; D012409:Rubella / Q000453:epidemiology* / Q000517:prevention & control*; D012411:Rubella Vaccine / Q000627:therapeutic use; D017678:Sex Distribution; D014611:Vaccination / Q000706:statistics & numerical data*; D014944:World Health Organization
chemical_list: D008458:Measles Vaccine; D012411:Rubella Vaccine